Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
about
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Self-assembling prodrugs.Enzymatically promoted release of organic molecules linked to magnetic nanoparticles.Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats
P2860
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@ast
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@en
type
label
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@ast
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@en
prefLabel
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@ast
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.
@en
P2860
P356
P1476
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging
@en
P2093
Caleb F Anderson
Honggang Cui
P2860
P304
P356
10.1021/ACS.IECR.7B00990
P407
P577
2017-04-24T00:00:00Z